{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:24Z","timestamp":1707524664039},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,25]]},"DOI":"10.7759\/cureus.28412","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:13:23Z","timestamp":1661472803000},"source":"Crossref","is-referenced-by-count":0,"title":["Myoclonic Jerks and Ataxia: A Case of Rare Neurological Side Effects of Amiodarone"],"prefix":"10.7759","author":[{"given":"Vanessa","family":"Milan-Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirudh R","family":"Damughatla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saivaishnavi","family":"Kamatham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zain N","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakeela","family":"Shakoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03850.x","article-title":"Severe muscle cramps after intravenous administration of amiodarone--a novel, potentially dose-dependent adverse effect","volume":"71","author":"Saha SA","year":"2011","unstructured":"Saha SA. Severe muscle cramps after intravenous administration of amiodarone--a novel, potentially dose-dependent adverse effect. Br J Clin Pharmacol. 2011, 71:624-5. 10.1111\/j.1365-2125.2010.03850.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.96","article-title":"Frequency, characteristics, and risk factors for amiodarone neurotoxicity","volume":"66","author":"Orr CF","year":"2009","unstructured":"Orr CF, Ahlskog JE. Frequency, characteristics, and risk factors for amiodarone neurotoxicity. Arch Neurol. 2009, 66:865-9. 10.1001\/archneurol.2009.96","journal-title":"Arch Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(83)90515-5","article-title":"Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation","volume":"52","author":"Morady F","year":"1983","unstructured":"Morady F, Sauve MJ, Malone P, et al.. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol. 1983, 52:975-9. 10.1016\/0002-9149(83)90515-5","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2020.110403","article-title":"Low-dose amiodarone is safe: a systematic review and meta-analysis","volume":"11","author":"Chokesuwattanaskul R","year":"2020","unstructured":"Chokesuwattanaskul R, Shah N, Chokesuwattanaskul S, Liu Z, Thakur R. Low-dose amiodarone is safe: a systematic review and meta-analysis. J Innov Card Rhythm Manag. 2020, 11:4054-61. 10.19102\/icrm.2020.110403","journal-title":"J Innov Card Rhythm Manag"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200575","article-title":"Ataxia: a diagnostic perplexity and management dilemma","volume":"2013","author":"Chaubey VK","year":"2013","unstructured":"Chaubey VK, Chhabra L, Kapila A. Ataxia: a diagnostic perplexity and management dilemma. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2013-200575","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s6611","article-title":"Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia","volume":"6","author":"Van Herendael H","year":"2010","unstructured":"Van Herendael H, Dorian P. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. Vasc Health Risk Manag. 2010, 6:465-72. 10.2147\/vhrm.s6611","journal-title":"Vasc Health Risk Manag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-020-1475-4","article-title":"Amiodarone-induced ataxia: a case report of severe cerebellar dysfunction and review of literature","volume":"25","author":"Sarrazin S","year":"2021","unstructured":"Sarrazin S, Hein C, Delrieu J, Crestani S, Menhour S, Gilbert-Fontan E, van Kan GA. Amiodarone-induced ataxia: a case report of severe cerebellar dysfunction and review of literature. J Nutr Health Aging. 2021, 25:284-6. 10.1007\/s12603-020-1475-4","journal-title":"J Nutr Health Aging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.06.093","article-title":"Severe ataxia caused by amiodarone","volume":"96","author":"Krauser DG","year":"2005","unstructured":"Krauser DG, Segal AZ, Kligfield P. Severe ataxia caused by amiodarone. Am J Cardiol. 2005, 96:1463-4. 10.1016\/j.amjcard.2005.06.093","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00220-9","article-title":"Adverse effects of low dose amiodarone: a meta-analysis","volume":"30","author":"Vorperian VR","year":"1997","unstructured":"Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol. 1997, 30:791-8. 10.1016\/s0735-1097(97)00220-9","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1017\/s0317167100018229","article-title":"A case of amiodarone-associated myoclonus responsive to levetiracetam","volume":"39","author":"Deik AF","year":"2012","unstructured":"Deik AF, Shanker VL. A case of amiodarone-associated myoclonus responsive to levetiracetam. Can J Neurol Sci. 2012, 39:680-1. 10.1017\/s0317167100018229","journal-title":"Can J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(20)33244-7","article-title":"Levetiracetam for the treatment of myoclonic neurotoxicity induced by amiodarone","volume":"75","author":"Celli D","year":"2020","unstructured":"Celli D, Penabad I, Marquez A, Byer M, Colombo R. Levetiracetam for the treatment of myoclonic neurotoxicity induced by amiodarone. J Am Coll Cardiol. 2020, 75:10.1016\/S0735-1097(20)33244-7","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106628-myoclonic-jerks-and-ataxia-a-case-of-rare-neurological-side-effects-of-amiodarone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:21Z","timestamp":1707508161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106628-myoclonic-jerks-and-ataxia-a-case-of-rare-neurological-side-effects-of-amiodarone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.28412","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,25]]}}}